Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Gender Reassignment Surgery Market

ID: MRFR/HC/40756-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026

Gender Reassignment Surgery Market Research Report: Size, Share, Trend Analysis By Types of Procedure (Male to Female Surgery, Female to Male Surgery, Non-Binary Surgery), By Surgical Technique (Vaginoplasty, Phalloplasty, Mastectomy, Facial Feminization Surgery, Breast Augmentation), By Age Group (18-24, 25-34, 35-44, 45-54), By Healthcare Setting (Hospitals, Ambulatory Surgical Centers, Specialized Clinics) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Gender Reassignment Surgery Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type of Procedure (USD Billion)
  49.     4.1.1 Male to Female Surgery
  50.     4.1.2 Female to Male Surgery
  51.     4.1.3 Non-Binary Surgery
  52.   4.2 Healthcare, BY Surgical Technique (USD Billion)
  53.     4.2.1 Vaginoplasty
  54.     4.2.2 Phalloplasty
  55.     4.2.3 Mastectomy
  56.     4.2.4 Facial Feminization Surgery
  57.     4.2.5 Breast Augmentation
  58.   4.3 Healthcare, BY Age Group (USD Billion)
  59.     4.3.1 18-24
  60.     4.3.2 25-34
  61.     4.3.3 35-44
  62.     4.3.4 45-54
  63.   4.4 Healthcare, BY Healthcare Setting (USD Billion)
  64.     4.4.1 Hospitals
  65.     4.4.2 Ambulatory Surgical Centers
  66.     4.4.3 Specialized Clinics
  67.   4.5 Healthcare, BY Region (USD Billion)
  68.     4.5.1 North America
  69.       4.5.1.1 US
  70.       4.5.1.2 Canada
  71.     4.5.2 Europe
  72.       4.5.2.1 Germany
  73.       4.5.2.2 UK
  74.       4.5.2.3 France
  75.       4.5.2.4 Russia
  76.       4.5.2.5 Italy
  77.       4.5.2.6 Spain
  78.       4.5.2.7 Rest of Europe
  79.     4.5.3 APAC
  80.       4.5.3.1 China
  81.       4.5.3.2 India
  82.       4.5.3.3 Japan
  83.       4.5.3.4 South Korea
  84.       4.5.3.5 Malaysia
  85.       4.5.3.6 Thailand
  86.       4.5.3.7 Indonesia
  87.       4.5.3.8 Rest of APAC
  88.     4.5.4 South America
  89.       4.5.4.1 Brazil
  90.       4.5.4.2 Mexico
  91.       4.5.4.3 Argentina
  92.       4.5.4.4 Rest of South America
  93.     4.5.5 MEA
  94.       4.5.5.1 GCC Countries
  95.       4.5.5.2 South Africa
  96.       4.5.5.3 Rest of MEA
  97. 5 SECTION V: COMPETITIVE ANALYSIS
  98.   5.1 Competitive Landscape
  99.     5.1.1 Overview
  100.     5.1.2 Competitive Analysis
  101.     5.1.3 Market share Analysis
  102.     5.1.4 Major Growth Strategy in the Healthcare
  103.     5.1.5 Competitive Benchmarking
  104.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  105.     5.1.7 Key developments and growth strategies
  106.       5.1.7.1 New Product Launch/Service Deployment
  107.       5.1.7.2 Merger & Acquisitions
  108.       5.1.7.3 Joint Ventures
  109.     5.1.8 Major Players Financial Matrix
  110.       5.1.8.1 Sales and Operating Income
  111.       5.1.8.2 Major Players R&D Expenditure. 2023
  112.   5.2 Company Profiles
  113.     5.2.1 Mayo Clinic (US)
  114.       5.2.1.1 Financial Overview
  115.       5.2.1.2 Products Offered
  116.       5.2.1.3 Key Developments
  117.       5.2.1.4 SWOT Analysis
  118.       5.2.1.5 Key Strategies
  119.     5.2.2 Cleveland Clinic (US)
  120.       5.2.2.1 Financial Overview
  121.       5.2.2.2 Products Offered
  122.       5.2.2.3 Key Developments
  123.       5.2.2.4 SWOT Analysis
  124.       5.2.2.5 Key Strategies
  125.     5.2.3 Mount Sinai Health System (US)
  126.       5.2.3.1 Financial Overview
  127.       5.2.3.2 Products Offered
  128.       5.2.3.3 Key Developments
  129.       5.2.3.4 SWOT Analysis
  130.       5.2.3.5 Key Strategies
  131.     5.2.4 Johns Hopkins Medicine (US)
  132.       5.2.4.1 Financial Overview
  133.       5.2.4.2 Products Offered
  134.       5.2.4.3 Key Developments
  135.       5.2.4.4 SWOT Analysis
  136.       5.2.4.5 Key Strategies
  137.     5.2.5 University of California, San Francisco (US)
  138.       5.2.5.1 Financial Overview
  139.       5.2.5.2 Products Offered
  140.       5.2.5.3 Key Developments
  141.       5.2.5.4 SWOT Analysis
  142.       5.2.5.5 Key Strategies
  143.     5.2.6 Gender Confirmation Center (US)
  144.       5.2.6.1 Financial Overview
  145.       5.2.6.2 Products Offered
  146.       5.2.6.3 Key Developments
  147.       5.2.6.4 SWOT Analysis
  148.       5.2.6.5 Key Strategies
  149.     5.2.7 Pride Health (US)
  150.       5.2.7.1 Financial Overview
  151.       5.2.7.2 Products Offered
  152.       5.2.7.3 Key Developments
  153.       5.2.7.4 SWOT Analysis
  154.       5.2.7.5 Key Strategies
  155.     5.2.8 Charing Cross Hospital (GB)
  156.       5.2.8.1 Financial Overview
  157.       5.2.8.2 Products Offered
  158.       5.2.8.3 Key Developments
  159.       5.2.8.4 SWOT Analysis
  160.       5.2.8.5 Key Strategies
  161.     5.2.9 Royal London Hospital (GB)
  162.       5.2.9.1 Financial Overview
  163.       5.2.9.2 Products Offered
  164.       5.2.9.3 Key Developments
  165.       5.2.9.4 SWOT Analysis
  166.       5.2.9.5 Key Strategies
  167.   5.3 Appendix
  168.     5.3.1 References
  169.     5.3.2 Related Reports
  170. 6 LIST OF FIGURES
  171.   6.1 MARKET SYNOPSIS
  172.   6.2 NORTH AMERICA MARKET ANALYSIS
  173.   6.3 US MARKET ANALYSIS BY TYPE OF PROCEDURE
  174.   6.4 US MARKET ANALYSIS BY SURGICAL TECHNIQUE
  175.   6.5 US MARKET ANALYSIS BY AGE GROUP
  176.   6.6 US MARKET ANALYSIS BY HEALTHCARE SETTING
  177.   6.7 CANADA MARKET ANALYSIS BY TYPE OF PROCEDURE
  178.   6.8 CANADA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  179.   6.9 CANADA MARKET ANALYSIS BY AGE GROUP
  180.   6.10 CANADA MARKET ANALYSIS BY HEALTHCARE SETTING
  181.   6.11 EUROPE MARKET ANALYSIS
  182.   6.12 GERMANY MARKET ANALYSIS BY TYPE OF PROCEDURE
  183.   6.13 GERMANY MARKET ANALYSIS BY SURGICAL TECHNIQUE
  184.   6.14 GERMANY MARKET ANALYSIS BY AGE GROUP
  185.   6.15 GERMANY MARKET ANALYSIS BY HEALTHCARE SETTING
  186.   6.16 UK MARKET ANALYSIS BY TYPE OF PROCEDURE
  187.   6.17 UK MARKET ANALYSIS BY SURGICAL TECHNIQUE
  188.   6.18 UK MARKET ANALYSIS BY AGE GROUP
  189.   6.19 UK MARKET ANALYSIS BY HEALTHCARE SETTING
  190.   6.20 FRANCE MARKET ANALYSIS BY TYPE OF PROCEDURE
  191.   6.21 FRANCE MARKET ANALYSIS BY SURGICAL TECHNIQUE
  192.   6.22 FRANCE MARKET ANALYSIS BY AGE GROUP
  193.   6.23 FRANCE MARKET ANALYSIS BY HEALTHCARE SETTING
  194.   6.24 RUSSIA MARKET ANALYSIS BY TYPE OF PROCEDURE
  195.   6.25 RUSSIA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  196.   6.26 RUSSIA MARKET ANALYSIS BY AGE GROUP
  197.   6.27 RUSSIA MARKET ANALYSIS BY HEALTHCARE SETTING
  198.   6.28 ITALY MARKET ANALYSIS BY TYPE OF PROCEDURE
  199.   6.29 ITALY MARKET ANALYSIS BY SURGICAL TECHNIQUE
  200.   6.30 ITALY MARKET ANALYSIS BY AGE GROUP
  201.   6.31 ITALY MARKET ANALYSIS BY HEALTHCARE SETTING
  202.   6.32 SPAIN MARKET ANALYSIS BY TYPE OF PROCEDURE
  203.   6.33 SPAIN MARKET ANALYSIS BY SURGICAL TECHNIQUE
  204.   6.34 SPAIN MARKET ANALYSIS BY AGE GROUP
  205.   6.35 SPAIN MARKET ANALYSIS BY HEALTHCARE SETTING
  206.   6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE OF PROCEDURE
  207.   6.37 REST OF EUROPE MARKET ANALYSIS BY SURGICAL TECHNIQUE
  208.   6.38 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP
  209.   6.39 REST OF EUROPE MARKET ANALYSIS BY HEALTHCARE SETTING
  210.   6.40 APAC MARKET ANALYSIS
  211.   6.41 CHINA MARKET ANALYSIS BY TYPE OF PROCEDURE
  212.   6.42 CHINA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  213.   6.43 CHINA MARKET ANALYSIS BY AGE GROUP
  214.   6.44 CHINA MARKET ANALYSIS BY HEALTHCARE SETTING
  215.   6.45 INDIA MARKET ANALYSIS BY TYPE OF PROCEDURE
  216.   6.46 INDIA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  217.   6.47 INDIA MARKET ANALYSIS BY AGE GROUP
  218.   6.48 INDIA MARKET ANALYSIS BY HEALTHCARE SETTING
  219.   6.49 JAPAN MARKET ANALYSIS BY TYPE OF PROCEDURE
  220.   6.50 JAPAN MARKET ANALYSIS BY SURGICAL TECHNIQUE
  221.   6.51 JAPAN MARKET ANALYSIS BY AGE GROUP
  222.   6.52 JAPAN MARKET ANALYSIS BY HEALTHCARE SETTING
  223.   6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE OF PROCEDURE
  224.   6.54 SOUTH KOREA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  225.   6.55 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP
  226.   6.56 SOUTH KOREA MARKET ANALYSIS BY HEALTHCARE SETTING
  227.   6.57 MALAYSIA MARKET ANALYSIS BY TYPE OF PROCEDURE
  228.   6.58 MALAYSIA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  229.   6.59 MALAYSIA MARKET ANALYSIS BY AGE GROUP
  230.   6.60 MALAYSIA MARKET ANALYSIS BY HEALTHCARE SETTING
  231.   6.61 THAILAND MARKET ANALYSIS BY TYPE OF PROCEDURE
  232.   6.62 THAILAND MARKET ANALYSIS BY SURGICAL TECHNIQUE
  233.   6.63 THAILAND MARKET ANALYSIS BY AGE GROUP
  234.   6.64 THAILAND MARKET ANALYSIS BY HEALTHCARE SETTING
  235.   6.65 INDONESIA MARKET ANALYSIS BY TYPE OF PROCEDURE
  236.   6.66 INDONESIA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  237.   6.67 INDONESIA MARKET ANALYSIS BY AGE GROUP
  238.   6.68 INDONESIA MARKET ANALYSIS BY HEALTHCARE SETTING
  239.   6.69 REST OF APAC MARKET ANALYSIS BY TYPE OF PROCEDURE
  240.   6.70 REST OF APAC MARKET ANALYSIS BY SURGICAL TECHNIQUE
  241.   6.71 REST OF APAC MARKET ANALYSIS BY AGE GROUP
  242.   6.72 REST OF APAC MARKET ANALYSIS BY HEALTHCARE SETTING
  243.   6.73 SOUTH AMERICA MARKET ANALYSIS
  244.   6.74 BRAZIL MARKET ANALYSIS BY TYPE OF PROCEDURE
  245.   6.75 BRAZIL MARKET ANALYSIS BY SURGICAL TECHNIQUE
  246.   6.76 BRAZIL MARKET ANALYSIS BY AGE GROUP
  247.   6.77 BRAZIL MARKET ANALYSIS BY HEALTHCARE SETTING
  248.   6.78 MEXICO MARKET ANALYSIS BY TYPE OF PROCEDURE
  249.   6.79 MEXICO MARKET ANALYSIS BY SURGICAL TECHNIQUE
  250.   6.80 MEXICO MARKET ANALYSIS BY AGE GROUP
  251.   6.81 MEXICO MARKET ANALYSIS BY HEALTHCARE SETTING
  252.   6.82 ARGENTINA MARKET ANALYSIS BY TYPE OF PROCEDURE
  253.   6.83 ARGENTINA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  254.   6.84 ARGENTINA MARKET ANALYSIS BY AGE GROUP
  255.   6.85 ARGENTINA MARKET ANALYSIS BY HEALTHCARE SETTING
  256.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE OF PROCEDURE
  257.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  258.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP
  259.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY HEALTHCARE SETTING
  260.   6.90 MEA MARKET ANALYSIS
  261.   6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE OF PROCEDURE
  262.   6.92 GCC COUNTRIES MARKET ANALYSIS BY SURGICAL TECHNIQUE
  263.   6.93 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP
  264.   6.94 GCC COUNTRIES MARKET ANALYSIS BY HEALTHCARE SETTING
  265.   6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE OF PROCEDURE
  266.   6.96 SOUTH AFRICA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  267.   6.97 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP
  268.   6.98 SOUTH AFRICA MARKET ANALYSIS BY HEALTHCARE SETTING
  269.   6.99 REST OF MEA MARKET ANALYSIS BY TYPE OF PROCEDURE
  270.   6.100 REST OF MEA MARKET ANALYSIS BY SURGICAL TECHNIQUE
  271.   6.101 REST OF MEA MARKET ANALYSIS BY AGE GROUP
  272.   6.102 REST OF MEA MARKET ANALYSIS BY HEALTHCARE SETTING
  273.   6.103 KEY BUYING CRITERIA OF HEALTHCARE
  274.   6.104 RESEARCH PROCESS OF MRFR
  275.   6.105 DRO ANALYSIS OF HEALTHCARE
  276.   6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  277.   6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  278.   6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
  279.   6.109 HEALTHCARE, BY TYPE OF PROCEDURE, 2024 (% SHARE)
  280.   6.110 HEALTHCARE, BY TYPE OF PROCEDURE, 2024 TO 2035 (USD Billion)
  281.   6.111 HEALTHCARE, BY SURGICAL TECHNIQUE, 2024 (% SHARE)
  282.   6.112 HEALTHCARE, BY SURGICAL TECHNIQUE, 2024 TO 2035 (USD Billion)
  283.   6.113 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE)
  284.   6.114 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Billion)
  285.   6.115 HEALTHCARE, BY HEALTHCARE SETTING, 2024 (% SHARE)
  286.   6.116 HEALTHCARE, BY HEALTHCARE SETTING, 2024 TO 2035 (USD Billion)
  287.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  288. 7 LIST OF TABLES
  289.   7.1 LIST OF ASSUMPTIONS
  290.     7.1.1
  291.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  292.     7.2.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  293.     7.2.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  294.     7.2.3 BY AGE GROUP, 2025-2035 (USD Billion)
  295.     7.2.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  296.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  297.     7.3.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  298.     7.3.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  299.     7.3.3 BY AGE GROUP, 2025-2035 (USD Billion)
  300.     7.3.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  301.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  302.     7.4.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  303.     7.4.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  304.     7.4.3 BY AGE GROUP, 2025-2035 (USD Billion)
  305.     7.4.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  306.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  307.     7.5.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  308.     7.5.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  309.     7.5.3 BY AGE GROUP, 2025-2035 (USD Billion)
  310.     7.5.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  311.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  312.     7.6.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  313.     7.6.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  314.     7.6.3 BY AGE GROUP, 2025-2035 (USD Billion)
  315.     7.6.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  316.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  317.     7.7.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  318.     7.7.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  319.     7.7.3 BY AGE GROUP, 2025-2035 (USD Billion)
  320.     7.7.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  321.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  322.     7.8.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  323.     7.8.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  324.     7.8.3 BY AGE GROUP, 2025-2035 (USD Billion)
  325.     7.8.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  326.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  327.     7.9.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  328.     7.9.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  329.     7.9.3 BY AGE GROUP, 2025-2035 (USD Billion)
  330.     7.9.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  331.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  332.     7.10.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  333.     7.10.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  334.     7.10.3 BY AGE GROUP, 2025-2035 (USD Billion)
  335.     7.10.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  336.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  337.     7.11.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  338.     7.11.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  339.     7.11.3 BY AGE GROUP, 2025-2035 (USD Billion)
  340.     7.11.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  341.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  342.     7.12.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  343.     7.12.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  344.     7.12.3 BY AGE GROUP, 2025-2035 (USD Billion)
  345.     7.12.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  346.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  347.     7.13.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  348.     7.13.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  349.     7.13.3 BY AGE GROUP, 2025-2035 (USD Billion)
  350.     7.13.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  351.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  352.     7.14.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  353.     7.14.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  354.     7.14.3 BY AGE GROUP, 2025-2035 (USD Billion)
  355.     7.14.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  356.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  357.     7.15.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  358.     7.15.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  359.     7.15.3 BY AGE GROUP, 2025-2035 (USD Billion)
  360.     7.15.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  361.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  362.     7.16.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  363.     7.16.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  364.     7.16.3 BY AGE GROUP, 2025-2035 (USD Billion)
  365.     7.16.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  366.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  367.     7.17.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  368.     7.17.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  369.     7.17.3 BY AGE GROUP, 2025-2035 (USD Billion)
  370.     7.17.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  371.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  372.     7.18.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  373.     7.18.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  374.     7.18.3 BY AGE GROUP, 2025-2035 (USD Billion)
  375.     7.18.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  376.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  377.     7.19.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  378.     7.19.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  379.     7.19.3 BY AGE GROUP, 2025-2035 (USD Billion)
  380.     7.19.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  381.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  382.     7.20.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  383.     7.20.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  384.     7.20.3 BY AGE GROUP, 2025-2035 (USD Billion)
  385.     7.20.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  386.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  387.     7.21.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  388.     7.21.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  389.     7.21.3 BY AGE GROUP, 2025-2035 (USD Billion)
  390.     7.21.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  391.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  392.     7.22.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  393.     7.22.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  394.     7.22.3 BY AGE GROUP, 2025-2035 (USD Billion)
  395.     7.22.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  396.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  397.     7.23.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  398.     7.23.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  399.     7.23.3 BY AGE GROUP, 2025-2035 (USD Billion)
  400.     7.23.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  401.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  402.     7.24.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  403.     7.24.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  404.     7.24.3 BY AGE GROUP, 2025-2035 (USD Billion)
  405.     7.24.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  406.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  407.     7.25.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  408.     7.25.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  409.     7.25.3 BY AGE GROUP, 2025-2035 (USD Billion)
  410.     7.25.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  411.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  412.     7.26.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  413.     7.26.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  414.     7.26.3 BY AGE GROUP, 2025-2035 (USD Billion)
  415.     7.26.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  416.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  417.     7.27.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  418.     7.27.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  419.     7.27.3 BY AGE GROUP, 2025-2035 (USD Billion)
  420.     7.27.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  421.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  422.     7.28.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  423.     7.28.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  424.     7.28.3 BY AGE GROUP, 2025-2035 (USD Billion)
  425.     7.28.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  426.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  427.     7.29.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  428.     7.29.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  429.     7.29.3 BY AGE GROUP, 2025-2035 (USD Billion)
  430.     7.29.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  431.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  432.     7.30.1 BY TYPE OF PROCEDURE, 2025-2035 (USD Billion)
  433.     7.30.2 BY SURGICAL TECHNIQUE, 2025-2035 (USD Billion)
  434.     7.30.3 BY AGE GROUP, 2025-2035 (USD Billion)
  435.     7.30.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion)
  436.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  437.     7.31.1
  438.   7.32 ACQUISITION/PARTNERSHIP
  439.     7.32.1

Healthcare Market Segmentation

Healthcare By Type of Procedure (USD Billion, 2025-2035)

  • Male to Female Surgery
  • Female to Male Surgery
  • Non-Binary Surgery

Healthcare By Surgical Technique (USD Billion, 2025-2035)

  • Vaginoplasty
  • Phalloplasty
  • Mastectomy
  • Facial Feminization Surgery
  • Breast Augmentation

Healthcare By Age Group (USD Billion, 2025-2035)

  • 18-24
  • 25-34
  • 35-44
  • 45-54

Healthcare By Healthcare Setting (USD Billion, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions